V

VKTX

Viking Therapeutics Inc

30.70

-0.93-2.94%
Closed19:52 07/15 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

0

0

0

0

0

Net Income

-109.96M

-85.89M

-68.87M

-54.99M

-39.49M

ROE

-0.179

-0.3479

-0.3967

-0.2465

-0.1515

ROA

-0.1722

-0.3199

-0.3632

-0.2354

-0.1461

EPS

-1.0085

-0.9104

-0.8963

-0.7123

-0.544

BVPS

7.8897

3.4802

1.857

2.58

3.3373

Asset Turnover

0

0

0

0

0

Debt-to-Asset

0.0309

0.0545

0.1377

0.0417

0.0474

Current Ratio

33.0944

19.1913

7.6111

23.9836

21.115

Quick Ratio

--

--

--

--

--